34results about How to "Facilitate the binding reaction" patented technology

The invention provides a graphene-based foamed ceramic insulation wallboard, which is made of the following components: potassium sodium feldspar, ceramic waste residue, graphene, vermiculite, high-temperature co-solvent, expanded graphite, zirconia, clay, stable agent and debonding agent. Using potassium sodium feldspar and ceramic waste slag as the base material, adding graphene and vermiculite to make the board more lightweight, high-strength, thermal insulation, and improve the performance of the board such as fire resistance, insulation and weather resistance, using expanded graphite as a foaming agent, using high temperature The foaming process can better control the density, pore distribution and pore size of the board, achieve better heat preservation and light weight effects, and make a board with remarkable anti-aging, corrosion resistance, heat insulation, sound insulation, waterproof and impervious, fireproof and fireproof. , lightweight, high-strength, non-cracking, green and environmental protection and other comprehensive performance in one foam lightweight wallboard.

The invention relates to a diffusion layer for an integrated regenerative fuel battery and preparation thereof. The diffusion layer consists of a substrate layer and a microporous layer which is coated on the substrate layer, wherein the microporous layer is formed by mixing an intermetallic compound and noble metal catalyst with a mass ratio of between 0.1:1 and 1:0.1. Compared with the prior art, the diffusion layer has the advantages that: firstly, the diffusion layer has good electrical conductivity; secondly, the diffusion layer has good chemical stability and electrochemical stability and superior corrosion resistance; thirdly, the diffusion layer has low cost; and fourthly, the diffusion layer has simple process and is easy to realize industrialization. Therefore, the novel diffusion layer adopting the intermetallic compound can obviously improve the cycle life of the regenerative fuel battery. The diffusion layer for the regenerative fuel battery with low cost and high durability can be prepared by the method. A regenerative fuel battery chip MEA and a single battery prepared by the prepared diffusion layer have good output performance.

The invention provides a graphene and stone tailing based foaming light heat insulation board. The graphene and stone tailing based foaming light heat insulation board is prepared from the following components of a stone tailing, clay, graphene, calcium carbonate, vermiculite, a high temperature cosolvent, expanded graphite, a stabilizer, a dispergator and a pigment. The heat insulation board usesthe stone tailing as the base material, the graphene and the vermiculite are added, then the board better achieves the advantages of light weight, high strength and heat insulation, the performancesof fireproofing, insulation and weatherproofing of the board are better improved, the expanded graphite is used as a foaming agent, the high temperature foaming process is used, the sectioned thermalinsulation mode is adopted in sintering, the hardness, the high temperature resistance and the flame retardance performance of the heat insulation board are improved, the density and the pore distribution of the board are better controlled, the better effects of heat insulation, light weight and high strength are achieved, and the heat insulation board further has the functional characteristics offireproofness, sound insulation, waterproofness, anti-aging, corrosion resistance, green and environmental protection.

The invention belongs to the field of building enclosure wall materials, and particularly relates to a graphene and nonmetallic tailing based foamed lightweight wallboard and a preparation method thereof. The graphene and nonmetallic tailing based foamed lightweight wallboard comprises the following components in percentage by weight: 55-75% of nonmetallic tailings, 0.05-15% of graphene, 1-15% ofvermiculite, 0.05-15% of a high-temperature cosolvent, 5-20% of high-temperature-resistant fiber, 0.05-5% of a foaming agent, 1-20% of zirconia, 1-10% of clay, 0.05-5% of a stabilizing agent and 0.05-5% of a peptizing agent. The invention has the advantages that the graphene and nonmetallic tailing based foamed lightweight wallboard has the comprehensive properties of obvious aging resistance, corrosion resistance, heat insulation, sound insulation, water resistance, permeation resistance, fire resistance, light weight, high strength, no cracking, environmental protection and the like, and isprepared by adopting a production preparation method which is green and low-carbon, high in efficiency, energy-saving, consumption-reducing, and simple and convenient in operation.

The invention belongs to the field of building enclosure wall materials and in particular relates to a graphene-based stone foamed lightweight wall plate and a preparation method thereof. The stone foamed lightweight wall plate contains the following components in percentage by weight: 45-90% of stone tailings, 0.05-10% of a high-temperature cosolvent, 0.05-15% of graphene, 0.05-5% of expanded graphite, 1-20% of zirconia, 0.05-10% of calcium carbonate, 1-10% of clay, 0.05-5% of a stabilizer, 0.05-5% of a dispergator and 0.05-5% of inorganic colors. The stone foamed lightweight wall plate has the advantages of integrating overall performances such as obvious aging resistance, corrosion resistance, heat insulation, sound insulation, water seepage resistance, fire resistance, lightweight, high strength, cracking resistance, greening and environment friendliness, the preparation method is simple and easy to operate, and the production process is green, low-carbon, high-efficiency, energy-saving and consumption-reducing.

The invention belongs to the field of building enclosure wall materials, and particularly relates to a graphene and stone tailing-based foamed lightweight high-temperature-resistant wallboard and a preparation method thereof. The wallboard comprises the following raw materials in percentage by weight: 40-65% of stone tailings, 0.05-15% of graphene, 1-30% of aluminum oxide, 1-15% of vermiculite, 0.05-10% of calcium carbonate, 0.05-15% of high temperature solvent, 5-30% of high-temperature resistance fiber grains, 0.05-5% of vesicant, 0.05-5% of stabilizer, 0.05-5% of dispergator, 1-10% of clay,and additional 0-5% of pigment. The wallboard has the advantages of integrating comprehensive anti-ageing, anti-corrosion, heat-insulation, soundproof, waterproof and anti-seepage, fireproof, 1000DEGC high-temperature-resistant properties, light weight and high strength and toughness, no cracking, environment protection and the like, and the preparation method is simple and easy to operate, theproduction process is green and low-carbon, high-efficiency, energy-saving and consumption-reducing, and high in automation.

The invention relates to a paper mill deodorant and a preparation method thereof. The preparation method comprises the following steps: adding ethylenediamine tetraacetic acid into water, stirring byusing a stirrer, fully dissolving, and adding a main complex stearic acid and a second complex to fully mix and dissolve; controlling the temperature of the solution, controlling the rotating speed ofthe stirrer, and adding potassium monopersulfate to prepare a stable potassium monopersulfate mixture A; and adding a buffer agent into the mixture A, controlling the pH value of the solution, addinga surfactant, stirring for a certain time, finally adding 2,2-dibromo-3-nitrilopropionamide, and uniformly mixing to obtain the deodorant. According to the invention, the stability of the deodorant is improved by adding various complexes, foul molecules are decomposed into water and carbon dioxide by utilizing oxygen free radicals, sulfuric acid free radicals and hydroxyl free radicals, the combination reaction of the deodorant and the foul molecules is promoted by utilizing the surfactant, and the propagation of microorganisms in a water body is inhibited by utilizing the sterilization disinfectant.

The invention discloses an AIDS (Acquired Immune Deficiency Syndrome) blood purification therapeutic apparatus, comprising a blood and blood serum separator capable of separating blood serum, single blood cell from multinucleated giant cells formed by inquilinous HIV (Human Immunodeficiency Virus) and comprising a purifier including an HIV antibody capable of being combined with the HIV, a CD4+T cell line and a hybridoma macrophage cell line. When blood flows through the separator, the multinucleated giant cells containing the HIV are filtered out; when the separated blood serum flows through the purifier, the HIV is adsorbed and cleaned by a purification agent; the purified blood serum and the single blood cell separated by the separator are converged and then are conveyed back to a body, so that the AIDS blood purification therapeutic aim of cleaning the HIV in and out of the blood cells is realized.

The invention provides an AIDS detoxification treatment instrument in the field of medicine. The AIDS detoxification treatment instrument is characterized in that blood and plasma separators capable of separating plasma, single blood cell and multinucleated giant cells formed by the lodging of HIV is prepared, an HIVgp120 antibody and an HIVgp41 antibody capable of combining HIV, an HIVgp120 antibody and a gp41 antibody capable of combining goat anti-Ig, and a hybridoma cell strain are prepared to serve as a cleaning agent, the cleaning agent is prepared in agar gel and is wrapped with a high polymer material to prepare a purifier, which constitutes key components of an extracorporeal blood circulation device with the separators together, when the blood flows by the blood separator, the multinucleated giant cells containing the HIV are filtered, when the plasma separated by the plasma separator flows by the purifier, the HIV therein is adsorbed and cleared by the cleaning agent, the purified plasma is conveyed back in vivo after being combined with a single blood cell separated by the plasma separator, and thus the AIDS blood purification treatment purpose of clearing the HIV inside and outside the cells is realized.

The invention discloses an aids immunotherapy instrument for the medical field. The aids immunotherapy instrument is characterized in that a blood separator and a plasma separator capable of separating plasma, single hemocytes and multinuclear giant cells formed due to HIV parasitism are prepared, an HIVgp120 antibody and an HIVgp41 antibody capable of being bound with the HIV, an HIVgp120 antibody and a gp41 antibody capable of being bound with goat-anti Ig, and a CD4+T cell strain are prepared and blended into agar gel as a purifying agent, a purifier is made in a high polymer material wrapping mode, and the purifier and the separators together form key parts of an external blood circulation device. When blood flows through the blood separator, multinuclear giant cells containing the HIV are filtered out; when plasma separated by the plasma separator flows through the purifier, the HIV in plasma is adsorbed and removed by the purifying agent, purified plasma and single hemocytes separated by the plasma separator are mixed and then transfused back into the body, and thus the aids blood purification treatment purpose of removing the HIV inside and outside hemocytes is achieved.

The invention relates to an aids immunotherapy adsorber, belonging to the field of medicine science. The aids immunotherapy adsorber is characterized in that HIV gp120 and gp41 antibodies are prepared by adopting genetic recombination and the hybridoma technology, anti-goat gp 120 and gp 41 antibodies are prepared by taking the prepared HIV gp120 and gp41 antibodies as antigens, agar gel is added according to a suitable ratio, a material with high biocompatibility is adopted for covering, so that the adsorber is prepared, the layering distribution with antibody titer from high to low and agar concentration from low to high is formed from an inlet to an outlet, the anti-goat gp 120 and gp 41 antibodies are completely combined, while HIV gp120 and gp 41 antibodies with high titer are left, in the extracorporeal circulation, when the separated plasma flows through the adsorber, the HIV forms the immobilized immune complex with the corresponding fixed antibody, and the immobilized immune complex is intercepted by the agar gel with high concentration and small micropores, and the plasma with HIV removed flows out from the adsorber, is mixed with hemocytes, and then is conveyed back to the body.

The invention discloses an AIDS immune cell therapy apparatus, which is applicable to the medicine field. The AIDS immune cell therapy apparatus is characterized in that blood and plasma separators, by which plasma, individual blood cells and multinuclear giant cells which are formed due to HIV boarding, are prepared; by virtue of an exogenous gene transfection technique, a CD4+T cell line, which can bond HIV, is prepared, the CD4+T cell line undergoes amplification and the CD4+T cell line is covered by virtue of a high-biocompatibility material, so that a purifier is prepared; and then, agarose, which is subjected to a gradient concentration, is added, and the CD4+T cell line in the purifier is immobilized so as to take an effect on adsorbing the HIV; the purifier, together with the separators, functions as key parts of an extracorporeal circulation device; when blood passes through the blood separator, the multinuclear giant cells which contain the HIV are filtered out, subsequently, when the plasma, which is separated by virtue of the plasma separator, passes through the purifier, HIV in the plasma is adsorbed and scavenged by virtue of a purifying agent, the purified plasma joins with the individual blood cells which are separated by virtue of the plasma separator, and then the plasma is returned back, so that the purpose of scavenging the HIVs inside and outside the blood cells by virtue of a detoxifying and purifying therapy is achieved.

The invention discloses an HIV-infected pregnant women blood purifier. The purifier comprises a major component which is a purifying column, the purifying column comprises multiple purification layers composed of CD4+T cell strains, hybridoma macrophage cell strains, free HIV antibodies, HIV antibodies bound to goat antibodies Ig and agarose capable of binding with HIV, and the purification layers form the purifying column; HIV in to-be-purified blood treated with a blood and plasma separator is adsorbed and removed by the cleaning agent, and purified plasma and single blood cells separated by the separator gather together prior to being transfused into bodies, and accordingly the purpose of HIV-infected blood purification treatment on HIV inside and outside blood cells is achieved.

The invention provides an AIDS biological cell therapeutic instrument in the field of medicine. The AIDS biological cell therapeutic instrument is characterized in that blood and plasma separators capable of separating plasma, single blood cell and multinucleated giant cells formed by the lodging of HIV is prepared, a hybridoma cell strain both keeping the phagocytic characteristics and performing infinite growth is prepared, the hybridoma cell strain is wrapped with a high polymer material to prepare a purifier after being amplified, then agarose having a gradient concentration is added to fix the hybridoma cell strain to swallow HIV, the purifier constitutes a critical extracorporeal circulation device with the separators together, when the blood flows by the blood separator, the multinucleated giant cells containing the HIV are filtered, when the plasma separated by the plasma separator flows by the purifier, the HIV therein is cleared by the cleaning agent, the purified plasma is conveyed back in vivo after being combined with a single blood cell separated by the plasma separator, and thus the purification treatment purpose of clearing the HIV inside and outside the blood cells is realized.

The invention discloses a method of utilizing tungsten powder and nickel powder as raw materials to prepare superfine tungsten carbide powder. The method comprises the steps: matching the tungsten powder and carbon black according to the matter amount ratio of 1 to (1 to 1.5) and then adding the nickel powder of 5 to 8% of the total mass fraction of the tungsten powder and the carbon black to prepare a mixed raw material; putting the mixed raw material into a ball milling tank of a ball milling machine, then adding a grinding ball and performing inert gas protection or vacuumizing treatment onthe ball milling tank; putting the ball milling tank into a hearth of the ball milling machine and starting the ball milling machine to ball mill the mixed raw material; warming the hearth which theball milling tank is arranged into to 750 to 850 DEG C and keeping the hearth warm for 50 to 80 hours; shutting down the ball milling machine, cooling the hearth to the room temperature and taking theball milling tank out to obtain the superfine tungsten carbide powder with uniform granularity. The method disclosed by the invention not only has the advantages of simple technology, low energy consumption and low cost, but also can shorten reaction time; thus, the method has very high industrial value.

The invention discloses an AIDS immune cell therapy apparatus, which is applicable to the medicine field. The AIDS immune cell therapy apparatus is characterized in that blood and plasma separators, by which plasma, individual blood cells and multinuclear giant cells which are formed due to HIV boarding, are prepared; by virtue of an exogenous gene transfection technique, a CD4+T cell line, which can bond HIV, is prepared, the CD4+T cell line undergoes amplification and the CD4+T cell line is covered by virtue of a high-biocompatibility material, so that a purifier is prepared; and then, agarose, which is subjected to a gradient concentration, is added, and the CD4+T cell line in the purifier is immobilized so as to take an effect on adsorbing the HIV; the purifier, together with the separators, functions as key parts of an extracorporeal circulation device; when blood passes through the blood separator, the multinuclear giant cells which contain the HIV are filtered out, subsequently, when the plasma, which is separated by virtue of the plasma separator, passes through the purifier, HIV in the plasma is adsorbed and scavenged by virtue of a purifying agent, the purified plasma joins with the individual blood cells which are separated by virtue of the plasma separator, and then the plasma is returned back, so that the purpose of scavenging the HIVs inside and outside the blood cells by virtue of a detoxifying and purifying therapy is achieved.

The invention relates to an immobilized algae ball and its preparation method and application. The preparation method of the immobilized algae ball is to first cultivate the microbial algae liquid, then prepare the algae mixed liquid and the algae cross-linking agent, add the microbial algae liquid to the algae mixed The embedding solution was obtained from the liquid, and the embedding solution was dripped into the algae cross-linking agent with a peristaltic pump to obtain immobilized algal bulbs. Acetyl tri-n-butyl citrate (ATBC) and chitosan are added to the algae mixture, which makes the obtained immobilized algae bulbs stronger and less prone to damage, and makes microalgae reproduce faster and more efficient in handling nitrogen and phosphorus. high. The immobilized algae balls prepared by the present invention only use acetyl tri-n-butyl citrate and chitosan as additives, and do not need to use a variety of materials to increase the mechanical strength of the immobilized algae balls, which simplifies the process and ensures the immobilized algae balls Good stability and activity, both of which are widely sourced, low in price, low in equipment requirements and low in toxicity to microorganisms, convenient for large-scale production, and cost-effective.

The invention relates to an immobilized algae ball and a preparation method and application thereof. The preparation method of the immobilized algae ball comprises the steps that firstly, a microbialalgae solution is cultured, then an algae mixed solution and an algae cross-linking agent are prepared, the microbial algae solution is added into the algae mixed solution to obtain an embedding solution, the embedding solution is dripped into the algae cross-linking agent by using a peristaltic pump, and the immobilized algae ball is obtained. Acetyl tri-n-butyl citrate (ATBC) and chitosan are added into the algae mixed solution, so that the obtained immobilized algae ball is higher in strength and not prone to damage, microalgae reproduction is faster, and the nitrogen and phosphorus treatment efficiency is higher. According to the prepared immobilized algae ball, only the ATBC and the chitosan are adopted as additives, a plurality of materials do not need to be used for improving the mechanical strength of the immobilized algae ball, the process is simplified, the good stability and activity of the immobilized algae ball are guaranteed, the ATBC and the chitosan are wide in source and low in price, the requirement for equipment is low, the toxicity to microorganisms is small, large-scale production is facilitated, and the immobilized algae ball is economical and efficient.

An AIDS detoxification treatment instrument used in the medical field, characterized in that it prepares a blood and plasma separator capable of separating plasma, single blood cells and multinucleated giant cells formed by inhabiting HIV, and prepares HIVgp120 antibodies and HIVgp41 antibodies that can bind HIV As well as HIV gp120 and gp41 antibodies combined with goat anti-Ig, and hybridoma macrophage cell lines, as purifiers, prepared in agar gel, wrapped with polymer materials to make a purifier, and together with the separator constitute the key to the extracorporeal blood circulation device When the blood flows through the blood separator, the multinucleated giant cells containing HIV are filtered out, and then when the plasma separated by the plasma separator flows through the purifier, the HIV in it is absorbed and removed by the purifier, and the purified plasma and plasma The single blood cells separated by the separator are confluent and then reinfused into the body, so as to achieve the purpose of AIDS blood purification treatment to remove HIV inside and outside the blood cells.

An HIV (human immunodeficiency virus) therapeutic apparatus for the field of medical science is characterized in that a separator capable of separating blood cells and plasma is prepared, HIV gp120 and gp41 antibodies and HIV gp120 and gp41 antibodies capable of combining anti-goat Ig are prepared, CD4+T cell lines and hybrid tumor macrophage cell lines retaining myogenic cell properties and capable of infinitely growing are built by exogenous gene transfection and hybridoma technology respectively, the cell lines are amplified and then distributed in agar gel, the agar gel is wrapped by high-biocompatibility materials to prepare a purifier, the gel forms layering distribution of antibody titer from high to low and agarose concentration from low to high from top to bottom, anti-goat Ig combined and free gp120 and gp41 antibodies, the CD4+T cell lines and the hybrid tumor macrophage cell lines are fixed to the agar gel to function in adsorbing HIV, the prepared purifier is combined with the separator and a control procedure in use, blood in extracorporeal circulation is divided into the plasma and the blood cells by the separator, the HIV in the plasma is filtered by the purifier, and then the plasma is converged with the blood cells and returned.

The invention discloses a method for making soup-stock rice through an electric cooker and the electric cooker capable of making the soup-stock rice, belongs to the field of kitchen cooking utensils, and solves the problems that an existing soup-stock rice making process is complex, and many cooking devices are used. According to the method for making soup-stock rice through the electric cooker, the electric cooker comprises an inner container, a heating device and a steamer arranged in the inner container, steaming holes for soup and steam to circulate are formed in the steamer, a soup-stock cooking cavity is formed between the steamer and the bottom of the inner container, the heating device heats soup-stock food materials in the soup-stock cooking cavity to form soup-stock, the soup-stock is heated to be boiled, and the rice in the steamer is cooked through the steaming holes, so that the soup-stock rice is formed. According to the electric cooker, the making procedures of the soup-stock and the soup-stock rice are integrated into the electric cooker, the soup-stock and the soup-stock rice can be cooked at a time through a common electric cooker, and time and equipment for making the soup-stock and the soup-stock rice are saved for a user.

The invention discloses a method for making soupy rice with an electric cooker and an electric rice cooker capable of making soupy rice, which belongs to the field of kitchen cooking utensils and solves the problems that the existing cooking process for soupy rice is complicated and uses many cooking equipment. The method for making soupy rice with the electric cooker of the present invention, The electric rice cooker includes an inner container, a heating device and a steamer placed in the inner container, the steamer is provided with steaming holes for circulation of soup and steam, and a soup stock is arranged between the steamer and the bottom of the inner container. In the cooking cavity, the heating device heats the stock material in the stock cooking cavity to form stock, and the stock is heated to boiling and cooks the rice in the steamer through the steaming holes to form stock rice. The invention integrates the production process of stock and rice in stock into the electric rice cooker, and the stock and rice in stock can be cooked at one time by using an ordinary electric cooker, saving time and equipment for making stock and rice in stock for users.

The invention relates to an aids immunotherapy adsorber, belonging to the field of medicine science. The aids immunotherapy adsorber is characterized in that HIV gp120 and gp41 antibodies are prepared by adopting genetic recombination and the hybridoma technology, anti-goat gp 120 and gp 41 antibodies are prepared by taking the prepared HIV gp120 and gp41 antibodies as antigens, agar gel is added according to a suitable ratio, a material with high biocompatibility is adopted for covering, so that the adsorber is prepared, the layering distribution with antibody titer from high to low and agar concentration from low to high is formed from an inlet to an outlet, the anti-goat gp 120 and gp 41 antibodies are completely combined, while HIV gp120 and gp 41 antibodies with high titer are left, in the extracorporeal circulation, when the separated plasma flows through the adsorber, the HIV forms the immobilized immune complex with the corresponding fixed antibody, and the immobilized immune complex is intercepted by the agar gel with high concentration and small micropores, and the plasma with HIV removed flows out from the adsorber, is mixed with hemocytes, and then is conveyed back to the body.

The invention discloses a silane-alumina wear-resistant coating on the surface of willow handicrafts, and relates to the technical field of handicrafts. The preparation method comprises the followingsteps: mixing alumina treated by vinyl trimethoxysilane with a 2-acrylamide-2-methylpropanesulfonic acid / epoxy resin solution to obtain a composite solution; under the action of a catalyst, modifyingthe composite solution by 2-methyl-2-acrylic acid-2-isocyanatoethyl ester to obtain a composite material; brushing the composite material on the surface of a willow handicraft; placing the brushed willow artware in a drying chamber, and drying to form a wear-resistant coating on the surface of the willow artware. The wear-resistant coating formed on the surface of the willow handicraft has a lowerfriction coefficient, and better wear resistance.

The invention discloses an AIDS blood purifier, and belongs to the medicine field. The AIDS blood purifier is characterized in that a separator, by which blood cells and plasma are separated, is prepared; by virtue of a hybridoma technique, a hybridoma macrophage cell line, which not only reserves the properties of original macrophages but also achieves indeterminate growth, is prepared and the hybridoma macrophage cell line undergoes amplification; an HIVgp120 and gp41 antibody and an HIVgp120 and gp41 antibody bonded with anti-goat Ig; the prepared materials (the antibodies) are prepared in agar gels; and the hybridoma macrophage cell line is covered by virtue of a high-biocompatibility material, so that the purifier is prepared; the gels are in layered distribution that an antibody titer is decreased from top to bottom and an agarose concentration is increased from top to bottom, wherein the gp120 and gp41 antibodies which are bonded and not bonded with the anti-goat Ig as well as hybridoma macrophage cells are immobilized in the agar gels so as to take an effect on adsorbing the HIV; the prepared purifier is used in combination of the separator and a regulating program; blood participating in extracorporeal circulation is separated into the plasma and the blood cells by virtue of the separator; and the plasma joins with the blood cells after HIV is filtered out by virtue of the purifier, and then the plasma is returned back.

The invention discloses an AIDS (Acquired Immune Deficiency Syndrome) blood purification therapeutic apparatus, comprising a blood and blood serum separator capable of separating blood serum, single blood cell from multinucleated giant cells formed by inquilinous HIV (Human Immunodeficiency Virus) and comprising a purifier including an HIV antibody capable of being combined with the HIV, a CD4+T cell line and a hybridoma macrophage cell line. When blood flows through the separator, the multinucleated giant cells containing the HIV are filtered out; when the separated blood serum flows through the purifier, the HIV is adsorbed and cleaned by a purification agent; the purified blood serum and the single blood cell separated by the separator are converged and then are conveyed back to a body, so that the AIDS blood purification therapeutic aim of cleaning the HIV in and out of the blood cells is realized.

An AIDS plasma purifier used in the medical field is characterized in that a separator capable of separating plasma and blood cells is prepared, and a hybridoma macrophage strain that retains the characteristics of the original macrophage and can grow infinitely is prepared by hybridoma technology. Source gene transfection to construct a CD4+ T cell line and use its surface-specific molecular antibody as a growth stimulant to amplify, prepare the prepared cell line in agar gel, and wrap it with a high biocompatibility material to form a purifier, so that the condensed The gel forms a layered distribution of agarose concentration from low to high from top to bottom, and the macrophage cell lines and CD4+ T cell lines fixed in it are used to adsorb HIV. The 1% agarose gel with a pore size of 85nm also has The purifier is used in combination with the separator and the control program to retain HIV of 100-120nm. The blood in extracorporeal circulation is divided into plasma and blood cells by the separator. After the plasma is filtered out by the purifier, it merges with blood cells and returns lose.

An AIDS purifying treatment instrument used in the medical field is characterized in that a blood separator and a plasma separator which can separate plasma, single blood cells and multinuclear giant cells formed due to HIV parasitism are prepared, a hybridoma macrophage line and a CD4+T cell line which can be bound with the HIV are prepared through the hybridoma technology and the exogenous gene transfection technology respectively, blended into agar gel as purifying agents and then wrapped with a high polymer material to be prepared into a purifier, and the purifier and the separators form key components of an extracorporeal blood circulation device together. When blood flows through the blood separator, multinuclear giant cells containing the HIV are filtered out; then, when plasma separated by the plasma separator flows through the purifier, the HIV in the plasma is adsorbed and removed by the purifying agents; the purified plasma and single blood cells separated by the plasma separator are converged and then transfused back. Thus, the purpose of AIDS purifying treatment for removing the HIV inside and outside blood cells is achieved.